Analysis of serum calprotectin levels in ménière’s patients and investigation of its effect on disease severity

Patients with Ménière's Disease exhibit elevated serum calprotectin levels during acute attacks, which correlate strongly with symptom duration and decrease significantly after treatment. These findings suggest that calprotectin may be a potential inflammatory biomarker associated with disease burden and treatment response in MD; however, longitudinal studies with larger cohorts are needed to determine its diagnostic and prognostic utility.